Search research articles
Contact Us
Filters
Showing results (121-130 of 300) with videos related to
Page
of 30
Sort By:
International Journal of Radiation Oncology, Biology, Physics
|
August 4, 2009
Involved field radiation after autologous stem cell transplant for diffuse large B-cell lymphoma in the rituximab era
Tithi Biswas, Sughosh Dhakal, Rui Chen, et al.
British Journal of Haematology
|
April 4, 2018
Second-line and subsequent therapy and outcomes for follicular lymphoma in the United States: data from the observational National LymphoCare Study
Brian K Link, Bann-Mo Day, Xiaolei Zhou, et al.
Leukemia & Lymphoma
|
July 9, 2016
Feasibility of interim positron emission tomography (PET)-adapted therapy in HIV-positive patients with advanced Hodgkin lymphoma (HL): a sub-analysis of SWOG S0816 Phase 2 trial
Alexey V Danilov, Hongli Li, Oliver W Press, et al.
Blood
|
June 25, 2015
Outcomes of transformed follicular lymphoma in the modern era: a report from the National LymphoCare Study (NLCS)
Nina D Wagner-Johnston, Brian K Link, Michelle Byrtek, et al.
Clinical Immunology (Orlando, Fla.)
|
January 31, 2012
Syk inhibition with fostamatinib leads to transitional B lymphocyte depletion
Paul M Barr, Chungwen Wei, James Roger, et al.
Molecular Cancer Therapeutics
|
June 5, 2019
Retraction: Obatoclax Interacts Synergistically with the Irreversible Proteasome Inhibitor Carfilzomib in GC- and ABC-DLBCL Cells <i>In Vitro</i> and <i>In Vivo</i>
Girija Dasmahapatra, Dmitry Lembersky, Minkyeong P Son, et al.
Journal of Adolescent and Young Adult Oncology
|
September 3, 2025
Real World Data Identifies Care Needs in Adolescent and Young Adult Patients with Lymphoma: A Matched Cohort Study
John Mariano, Myla Strawderman, Eric Snyder, et al.
Leukemia & Lymphoma
|
October 26, 2020
Toxicity patterns of novel PI3K combinations in patients with non-Hodgkin lymphoma
Thomas D Rodgers, AnnaLynn M Williams, Andrea Baran, et al.
American Journal of Hematology
|
July 24, 2023
Long-term results of vaccination with adjuvanted recombinant varicella zoster glycoprotein E during initial Bruton tyrosine kinase inhibitors therapy for chronic lymphocytic leukemia or lymphoplasmacytic lymphoma
Michael T Brady, Nathan Laniewski, Myla Strawderman, et al.
Journal of Geriatric Oncology
|
March 7, 2026
Brentuximab vedotin and dose attenuated chemoimmunotherapy for patients 75 years and older with diffuse large B-cell lymphoma with analysis of outcomes by frailty
Patrick M Reagan, Allison Magnuson, Craig A Portell, et al.
Page
of 30
Search research articles
Search
Showing results (121-130 of 300) with videos related to
Sort By:
Page
of 30
International Journal of Radiation Oncology, Biology, Physics
|
August 4, 2009
Involved field radiation after autologous stem cell transplant for diffuse large B-cell lymphoma in the rituximab era
Tithi Biswas, Sughosh Dhakal, Rui Chen, et al.
British Journal of Haematology
|
April 4, 2018
Second-line and subsequent therapy and outcomes for follicular lymphoma in the United States: data from the observational National LymphoCare Study
Brian K Link, Bann-Mo Day, Xiaolei Zhou, et al.
Leukemia & Lymphoma
|
July 9, 2016
Feasibility of interim positron emission tomography (PET)-adapted therapy in HIV-positive patients with advanced Hodgkin lymphoma (HL): a sub-analysis of SWOG S0816 Phase 2 trial
Alexey V Danilov, Hongli Li, Oliver W Press, et al.
Blood
|
June 25, 2015
Outcomes of transformed follicular lymphoma in the modern era: a report from the National LymphoCare Study (NLCS)
Nina D Wagner-Johnston, Brian K Link, Michelle Byrtek, et al.
Clinical Immunology (Orlando, Fla.)
|
January 31, 2012
Syk inhibition with fostamatinib leads to transitional B lymphocyte depletion
Paul M Barr, Chungwen Wei, James Roger, et al.
Molecular Cancer Therapeutics
|
June 5, 2019
Retraction: Obatoclax Interacts Synergistically with the Irreversible Proteasome Inhibitor Carfilzomib in GC- and ABC-DLBCL Cells <i>In Vitro</i> and <i>In Vivo</i>
Girija Dasmahapatra, Dmitry Lembersky, Minkyeong P Son, et al.
Journal of Adolescent and Young Adult Oncology
|
September 3, 2025
Real World Data Identifies Care Needs in Adolescent and Young Adult Patients with Lymphoma: A Matched Cohort Study
John Mariano, Myla Strawderman, Eric Snyder, et al.
Leukemia & Lymphoma
|
October 26, 2020
Toxicity patterns of novel PI3K combinations in patients with non-Hodgkin lymphoma
Thomas D Rodgers, AnnaLynn M Williams, Andrea Baran, et al.
American Journal of Hematology
|
July 24, 2023
Long-term results of vaccination with adjuvanted recombinant varicella zoster glycoprotein E during initial Bruton tyrosine kinase inhibitors therapy for chronic lymphocytic leukemia or lymphoplasmacytic lymphoma
Michael T Brady, Nathan Laniewski, Myla Strawderman, et al.
Journal of Geriatric Oncology
|
March 7, 2026
Brentuximab vedotin and dose attenuated chemoimmunotherapy for patients 75 years and older with diffuse large B-cell lymphoma with analysis of outcomes by frailty
Patrick M Reagan, Allison Magnuson, Craig A Portell, et al.
Page
of 30